• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Primary Elements

Article

WellPoint is coupling together a new portfolio of payment for its PCPs, offering them more cash and fewer hassles.

Key Points

Many Americans feel overworked and underpaid these days-including primary care physicians (PCPs). To fortify the delivery of primary care, WellPoint is coupling together a new portfolio of payment for its 100,000 network PCPs, offering them more cash and fewer hassles.

"In virtually every health system that's been looked at in the United States and internationally, a strong foundation of a primary care physician coordinating care for a patient is the winning strategy," Dr. Nussbaum says.

"We need new payment models to engage physicians differently than what we have today," Dr. Nussbaum says. "And, those new models have to include paying for the really difficult and challenging work of coordinating care. It can't just be visit-based, and we believe that ultimately, if we have this shared accountability for quality and affordability, that will be the overall strategy."

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.